Posted by Michael Wonder on 09 Sep 2020
Scottish Medicines Consortium accepts nasal spray for depression previously rejected by NICE
8 September 2020 - Esketamine nasal spray can now be provided on the NHS in Scotland for adults with major depressive disorder.
The Scottish Medicines Consortium has accepted the use of esketamine (Spravato; Janssen) nasal spray for use within NHS Scotland for adults with treatment-resistant major depressive disorder.
This is in contrast to draft guidance published by the National Institute for Health and Care Excellence, which did not recommend the nasal spray medicine for treatment-resistant depression.
